首页> 外文OA文献 >High Resolution Mass Spectrometric Analysis of Secoiridoids and Metabolites as Biomarkers of Acute Olive Oil Intake-An Approach to Study Interindividual Variability in Humans
【2h】

High Resolution Mass Spectrometric Analysis of Secoiridoids and Metabolites as Biomarkers of Acute Olive Oil Intake-An Approach to Study Interindividual Variability in Humans

机译:Secoiridoids和代谢物的高分辨率质谱分析作为急性橄榄油摄入的生物标志物 - 一种研究人类中的近似性变异性的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scope: Phenolic compounds are minor components of extra virgin olive oil (EVOO). Secoiridoids are the major components contributing to the phenolic content of EVOO. {Silva, 2015 #95}Information is lacking regarding their potential as biomarkers for EVOO intake.udMethods and results: Healthy volunteers (n = 9) ingested 50 mL of EVOO in a single dose containing 322 mg/kg total phenolic content (caffeic acid equivalents) and 6 mg/20g hydroxytyrosol and its derivatives. Plasma was collected before (0h) and at 0.5, 1, 2, 4 and 6h after ingestion. Urine samples were collected prior to ingestion (0h) and at 0–4, 4–8, 8–15 and 15–24h. Samples were analysed by UPLC coupled with an Exactive Orbitrap MS. Partial Least Squares Discriminant Analysis with Orthogonal Signal Correction was applied to screen for metabolites that allowed samples discrimination. Plasma biomarkers and urine biomarkers were selected although individual variability was observed among volunteers. Results are in accordance with in vitro experiments performed (in vitro digestion and hepatic microsomal activity assays).udConclusions: Plasma (elenolic acid + H2; p-HPEA-EA + H2 + glucuronide) and urinary (3,4-DHPEA-EA, 3,4-DHPEA-EA + H2+glucuronide, methyl 3,4-DHPEA-EA + H2+glucuronide) secoiridoid compounds were selected as biomarkers to monitor EVOO intake showing good predictive ability according to multivariate analysis.
机译:范围:酚类化合物是特级初榨橄榄油(Evoo)的次要组件。 Secoiridoids是有助于evoo酚类含量的主要组分。 {SILVA,2015年#95}信息缺乏其作为EVOO Intake的生物标志物的潜力。 UDMethods和结果:健康志愿者(n = 9)在含有322mg / kg总酚含量的单剂量中摄取50毫升EVOO(咖啡酸等同物)和6mg / 20g羟基吡咯和其衍生物。在摄入后(0H)之前收集血浆和0.5,1,2,4和6h。在摄入(0H)之前收集尿液样品,在0-4,4-8,8-15和15-24h处收集。通过UPLC与辐射壁图MS耦合分析样品。利用正交信号校正的局部最小二乘判别分析应用于允许样品辨别的代谢物的筛选。选择血浆生物标志物和尿生物标志物,尽管在志愿者中观察到各个变异性。结果符合体外实验(体外消化和肝微粒体活性测定)。 Udconclusions:血浆(elenolic acid + H2; p-hpea-EA + H2 +葡糖醛酸)和尿(3,4-Dhpea-EA)选择3,4-DHPEA-EA + H2 +葡糖醛,甲基3,4-DHPEA-EA + H2 +葡糖醛酸酯)SecoIridoid化合物作为生物标志物,以监测evoo摄入量,根据多变量分析显示出良好的预测能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号